Skip to content
★ Sign in to follow
CL

Christina Lee Jenkins MD

Board Director
Director
Predictive Oncology Inc.
Total declarations
6
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 05 Jul 2022 for Predictive Oncology Inc..

Insider track record

Disclosed buys
0
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Christina Lee Jenkins MD: trading record in brief

Christina Lee Jenkins MD (board member) discloses dealings in Axe Compute Inc. to SEC (Form 4). In total, 6 filings cover trades dated from 21 April 2021 to 1 July 2022.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 5 July 2022, reports a share grant in Axe Compute Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Christina Lee Jenkins MD

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total

5 of 5 declarations